| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | Injection |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
INDICATIONS
It is indicated for cerebral vasospasm after subarachnoid space hemorrhage of various causes and for improving blood circulation during the recovery period of acute cerebrovascular disease...
Adverse reaction
A large number of clinical practices have shown that about 11.2% of patients with subarachnoid hemorrhage experienced adverse reactions when treated with nimodipine. The most common adverse reactions include: 1. decrease in blood pressure, the degree of which is related to the drug dose. 2. hepatitis. 3. skin tingling. 4. gastrointestinal bleeding. 5. thrombocytopenia. 6. occasional transient dizziness, headache, flushing, vomiting, gastrointestinal discomfort, etc. In addition, individual patients may have elevated alkaline phosphatase (ALP) and lactate dehydrogenase (LDH), elevated blood glucose, and elevated platelet count in some individuals.
| Support OEM/ODM |
Yes |
| Standard Available |
CP,BP |
| Documents |
GMP,COPP,FSC,CTD |
){kind=link}